Efficacy and Safety of Prophylactic Agents in Prevention of Retinopathy of Prematurity: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Objective Retinopathy of prematurity (ROP) is a leading cause of preventable childhood blindness in preterm infants with low birth weight. The efficacy and safety of prophylactic agents, including vitamin A, propranolol and lipids, in reducing ROP incidence remain unclear. This systematic review and...
Saved in:
Main Authors: | Waleed T Batais, Nada O Taher, Abeer K Alhindi, Abdullah A Ghaddaf, Anas Alamoudi, Sarah A Al-Ghamdi, Jumanah J Homsi, Hashem S Almarzouki, Mansour A Qurashi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-12-01
|
Series: | BMJ Open Ophthalmology |
Online Access: | https://bmjophth.bmj.com/content/9/1/e001910.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prophylactic Administration of Surfactant in Extremely Premature Infants
by: Lutz Koch, et al.
Published: (2010-01-01) -
Analysis of Salivary Cytokines in Retinopathy of Prematurity
by: Hwa-Shiu Wu, et al.
Published: (2025-01-01) -
Persistence of Retinopathy of Prematurity in an Infant with Tetralogy of Fallot
by: Murat Gunay, et al.
Published: (2016-01-01) -
Early applicability of retinopathy of prematurity score (ROPScore) and serum insulin growth factor-1 (IGF-1) for predicting treatment-requiring retinopathy of prematurity: a prospective cohort study
by: Aliaa Adel Ali, et al.
Published: (2025-01-01) -
Abnormal Expression of Peripheral Blood Leukocyte Surface Markers in Retinopathy of Prematurity Patients
by: Guo R, et al.
Published: (2025-02-01)